Third-Generation Anti-Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis.

Andrea Di MatteoKulveer MankiaLaurence DuquenneMichael MahlerDiane CorscaddenKatie MbaraLeticia Garcia-MontoyaJacqueline L NamPaul Emery

Published in: Arthritis & rheumatology (Hoboken, N.J.) (2020)

Anti-CCP3 antibodies improve the prediction of inflammatory arthritis in anti-CCP2+ at-risk individuals. The impact of anti-CCP3 antibody status for the risk stratification of individuals with high-titer anti-CCP2 is particularly notable.

Keyphrases

rheumatoid arthritis
systemic sclerosis